Z-1525-2021 Class II Ongoing

Recalled by Medtronic Inc., Cardiac Rhythm And Heart Failure (CRHF) — Mounds View, MN

FDA device recall Z-1525-2021 was initiated by Medtronic Inc., Cardiac Rhythm And Heart Failure (CRHF) on Apr 6, 2021 and is designated Class II. Reason for recall: A longevity estimation error may occur in the early years of device life when a unipolar pacing vector is programmed in the right atrial (RA) lead and/or the right ventricular (RV) lead. No other… The recall status is ongoing. Affected quantity: 575815 units.

Recall details

Product Type
Devices
Report Date
May 12, 2021
Initiation Date
Apr 6, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
575815 units

Product description

Implantable Pulse Generators - Product Usage: used to treat arrhythmias related to bradycardia. Additionally, CRT-P devices can also provide cardiac resynchronization therapy (CRT) in treatment of heart failure. 1. Azure family: Azure XT DR MRI SureScan", Azure S DR MRI SureScan, Azure XT SR MRI SureScan, Azure S SR MRI SureScan. 2. Astra family: Astra XT DR MRI SureScan, Astra XT SR MRI SureScan.

Reason for recall

A longevity estimation error may occur in the early years of device life when a unipolar pacing vector is programmed in the right atrial (RA) lead and/or the right ventricular (RV) lead. No other device features or therapies are impacted.

Distribution pattern

Worldwide distribution.

Code information

all codes

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1525-2021
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1525-2021. Report a data issue: hello@regdatalab.com.